Contract notice: Pharmaceutical products Tender, Germany - 14897306

Procurement Summary

Country : Germany

Summary : Contract notice: Pharmaceutical products

Deadline : 31 Aug 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 14897306

Document Ref. No. : 273942-2017

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : TECHNIKER KRANKENKASSE
Office Name: Techniker Krankenkasse
Address: Bramfelder Str. 140
Town: Hamburg
Postal Code: 22305




Germany
Email :openhouse-biologika@tk.de
URL :www.tk.de/vergabe

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: The most economic tender
CPV code: 33600000, 33600000
CPV Description: Pharmaceutical products.

"Open-House-Biologika-2017-06" Conclusion of non-exclusive discount agreements with the active substance insulin glargine (potency 100 U / ml) with any time of accession - 130a (8) to the active substance insulin glargine (potency 100 U / ml)U this open-house biologics procedure is possible at any time within the contract term. A contract is concluded with all pharmaceutical entrepreneurs who meet the requirements of Annex 4 to the contract (self-declaration for admission and the company) and certify this by their signature.

This notice does not concern the award of a public tender-(2014/24 / EC) and the antitrust law. In the interest of the broadest possible information to the interested pharmaceutical entrepreneurs, this notice will be published in the Supplement to the Official Journal of the European Union. The name of the procedure "Open procedure" used in the context of the present notice text (point IV.1.1)) And the indication of the award criteria (point II.2.5)) are owed to the specifications of the notification form and have no further meaning. With this, as well as with the use of the medium "TED", there is no submission to any legal regulations, the validity of which is not obligatoryAttvertraege only with pharmaceutical entrepreneurs i. P. - 4 para. 18 AMG, whereby the property of the contractual partners as pharmaceutical entrepreneurs refers to the drugs offered in each case. It should be noted that medicinal products within the scope of the AMG may only be placed on the market by a pharmaceutical contractor who is established-Within the scope of the AMG, in another Member State of the European Union or in another Contracting State to the Agreement on the European Economic Area (Section 9 (2), first sentence, of the AMG). Local representatives of a pharmaceutical entrepreneur can only participate if they are themselves pharmaceutical entrepreneurs, P. - 4 para. 18 AMG with regard to the respectively offered

The questions concerning the procedure or the participation and contract documents are available exclusively by means of a central contact person E-mail to the address specified in point I.1) of the contract notice. Here isT the name of the procedure "Open-House Biologika 2017-6" for the purpose of assignment.) Note to section I.3): The participation and contract documents will be available to all pharmaceutical entrepreneurs as defined in section II.2.4) and III.1.1) (Note IV.2.7): Access to this open-house biologic procedure is possible at any time within the term of the contract, All contract offers are opened and checked with the entrance. Please note that the notification for discount medicines in pharmacy software for the first calendar month can only be guaranteed if the written contract documents are complete and signed up to the third of the respective previous month of the TC. The date of the inbox is validS at the TK (see participation and contract documents)
Internet address (URL): www.tk.de/vergabe
Directive: Classical Directive (2014/24/EU)

Documents

 Tender Notice